“…Although QC and isoQC exhibit nearly identical substrate specificity in vitro, data from knockout mice indicate that QC and isoQC have preference for different peptides and proteins 4 . Since important substrates, such as CCL2, MCP-1, and amyloid-β, have been identified for QC/isoQC, QC/isoQC are regarded as potential therapeutic targets for inflammatory disease, Huntington's disease and Alzheimer disease 5,6 . Although studies suggest that QC/isoQC may be a risk factor for chronic lymphocytic leukemia and thyroid carcinomas 7 , it is largely unknown whether QC/isoQC, especially isoQC, play any role in cancer development, especially cancer immune surveillance.…”